Tissue-type plasminogen activator and fibrin monomers synergistically cause platelet dysfunction during retransfusion of shed blood after cardiopulmonary bypass.
暂无分享,去创建一个
[1] R. Colman,et al. Invited letter concerning: aprotinin. , 1991, The Journal of thoracic and cardiovascular surgery.
[2] J. Soria,et al. Temperature dependence of plasmin-induced activation or inhibition of human platelets. , 1991, Blood.
[3] C. Soria,et al. Differential redistribution of platelet glycoproteins Ib and IIb-IIIa after plasmin stimulation. , 1991, Blood.
[4] A. Michelson,et al. Plasmin-induced redistribution of platelet glycoprotein Ib. , 1990, Blood.
[5] W. van Oeveren,et al. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. , 1990, The Journal of thoracic and cardiovascular surgery.
[6] I. Goel,et al. Prophylactic tranexamic acid decreases bleeding after cardiac operations. , 1990, The Journal of thoracic and cardiovascular surgery.
[7] A. Vaheri,et al. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants , 1989, The Journal of cell biology.
[8] B. Adelman,et al. Plasminogen interactions with platelets in plasma , 1988 .
[9] E. Plow,et al. The cell-binding domains of plasminogen and their function in plasma. , 1988, Journal of Biological Chemistry.
[10] K. Sletten,et al. Competitions between fibrinogen with its degradation products for interactions with the platelet-fibrinogen receptor. , 1986, Thrombosis research.
[11] D. T. Shiu,et al. Activation of plasminogen by tissue plasminogen activator on normal and thrombasthenic platelets: effects on surface proteins and platelet aggregation. , 1986, Blood.
[12] J. White,et al. Plasminogen interacts with human platelets through two distinct mechanisms. , 1986, The Journal of clinical investigation.
[13] D. Cosgrove. An improved technique for autotransfusion of shed mediastinal blood. , 1985, Health matrix.
[14] R. Wilson,et al. Hemostasis Changes During Cardiopulmonary Bypass Surgery , 1985, Seminars in thrombosis and hemostasis.
[15] L. Eysman,et al. Reduced platelet activation and improved hemostasis after controlled cardiotomy suction during clinical membrane oxygenator perfusions. , 1985, The Journal of thoracic and cardiovascular surgery.
[16] E. Plow,et al. Binding and activation of plasminogen on the platelet surface. , 1985, The Journal of biological chemistry.
[17] J. Loscalzo,et al. Plasmin effect on platelet glycoprotein Ib-von Willebrand factor interactions. , 1985, Blood.
[18] C. Kluft,et al. Enhanced fibrinolytic activity during cardiopulmonary bypass in open‐heart surgery in man is caused by extrinsic (tissue‐type) plasminogen activator , 1984, European journal of clinical investigation.
[19] J. Verheijen,et al. Activation of plasminogen by tissue activator is increased specifically in the presence of certain soluble fibrin(ogen) fragments. , 1982, Thrombosis research.
[20] M. Hoylaerts,et al. Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. , 1982, The Journal of biological chemistry.